Thapa K, Ghimire B, Pokharel K, Cai M, Savontaus E, Rinne P
Int J Obes (Lond). 2024; 48(11):1625-1637.
PMID: 39117851
PMC: 11502480.
DOI: 10.1038/s41366-024-01600-9.
Irabuena C, Posada L, Colombo S, Aubriot L, Rey L, Villalba J
ACS Omega. 2024; 9(18):20167-20175.
PMID: 38737041
PMC: 11079878.
DOI: 10.1021/acsomega.4c00311.
Suominen A, Saldo Rubio G, Ruohonen S, Szabo Z, Pohjolainen L, Ghimire B
EMBO Rep. 2024; 25(4):1987-2014.
PMID: 38454158
PMC: 11014855.
DOI: 10.1038/s44319-024-00109-6.
Thapa K, Kadiri J, Saukkonen K, Pennanen I, Ghimire B, Cai M
Elife. 2023; 12.
PMID: 37490042
PMC: 10368426.
DOI: 10.7554/eLife.84782.
Katoh T, Suga H
Philos Trans R Soc Lond B Biol Sci. 2023; 378(1871):20220038.
PMID: 36633283
PMC: 9835608.
DOI: 10.1098/rstb.2022.0038.
Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment.
Cobongela S, Makatini M, Mdluli P, Sibuyi N
Pharmaceutics. 2022; 14(9).
PMID: 36145704
PMC: 9502522.
DOI: 10.3390/pharmaceutics14091956.
Applying Promiscuous RiPP Enzymes to Peptide Backbone -Methylation Chemistry.
Sarkar S, Gu W, Schmidt E
ACS Chem Biol. 2022; 17(8):2165-2178.
PMID: 35819062
PMC: 9526446.
DOI: 10.1021/acschembio.2c00293.
First total synthesis of versicotide A, B and C.
Posada L, Davyt D, Serra G
RSC Adv. 2022; 10(71):43653-43659.
PMID: 35519702
PMC: 9058379.
DOI: 10.1039/d0ra09635k.
Demonstration of a Common DPhe to DNal(2') Peptide Ligand Antagonist Switch for Melanocortin-3 and Melanocortin-4 Receptors Identifies the Systematic Mischaracterization of the Pharmacological Properties of Melanocortin Peptides.
Gimenez L, Noblin T, Williams S, Bagchi S, Ji R, Tao Y
J Med Chem. 2022; 65(8):5990-6000.
PMID: 35404053
PMC: 9059122.
DOI: 10.1021/acs.jmedchem.1c01295.
Aged Brains Express Less Melanocortin Receptors, Which Correlates with Age-Related Decline of Cognitive Functions.
Zhou Y, Chawla M, Rios-Monterrosa J, Wang L, Zempare M, Hruby V
Molecules. 2021; 26(20).
PMID: 34684847
PMC: 8541441.
DOI: 10.3390/molecules26206266.
Biosynthetic Strategies for Macrocyclic Peptides.
Wang W, Khojasteh S, Su D
Molecules. 2021; 26(11).
PMID: 34206124
PMC: 8199541.
DOI: 10.3390/molecules26113338.
Influence of -Methylation and Conformation on Almiramide Anti-Leishmanial Activity.
Nguyen A, Brettell S, Douanne N, Duquette C, Corbeil A, Fajardo E
Molecules. 2021; 26(12).
PMID: 34204673
PMC: 8231256.
DOI: 10.3390/molecules26123606.
Pursuing Orally Bioavailable Hepcidin Analogues via Cyclic -Methylated Mini-Hepcidins.
Goncalves Monteiro D, van Dijk J, Aliyanto R, Fung E, Nemeth E, Ganz T
Biomedicines. 2021; 9(2).
PMID: 33567510
PMC: 7915682.
DOI: 10.3390/biomedicines9020164.
Methodologies for Backbone Macrocyclic Peptide Synthesis Compatible With Screening Technologies.
Shinbara K, Liu W, van Neer R, Katoh T, Suga H
Front Chem. 2020; 8:447.
PMID: 32626683
PMC: 7314982.
DOI: 10.3389/fchem.2020.00447.
Selective Cyclized α-Melanocyte-Stimulating Hormone Derivative with Multiple -Methylations for Melanoma Imaging with Positron Emission Tomography.
Zhang C, Zhang Z, Zeisler J, Colpo N, Lin K, Benard F
ACS Omega. 2020; 5(19):10767-10773.
PMID: 32455196
PMC: 7240809.
DOI: 10.1021/acsomega.0c00310.
Diverse N-Substituted Azole-Containing Amino Acids as Building Blocks for Cyclopeptides.
Motevalli S, Nguyen M, Tan J, Fuller A
ACS Omega. 2020; 5(2):1214-1220.
PMID: 31984279
PMC: 6977196.
DOI: 10.1021/acsomega.9b03682.
Understanding Cell Penetration of Cyclic Peptides.
Dougherty P, Sahni A, Pei D
Chem Rev. 2019; 119(17):10241-10287.
PMID: 31083977
PMC: 6739158.
DOI: 10.1021/acs.chemrev.9b00008.
Synthesis, Profiling, and in Vivo Evaluation of Cyclopeptides Containing -Methyl Amino Acids as Antiplasmodial Agents.
Fagundez C, Sellanes D, Pena S, Scarone L, Aguiar A, de Souza J
ACS Med Chem Lett. 2019; 10(1):137-141.
PMID: 30655961
PMC: 6331169.
DOI: 10.1021/acsmedchemlett.8b00543.
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors.
Merlino F, Zhou Y, Cai M, Carotenuto A, Yousif A, Brancaccio D
J Med Chem. 2018; 61(9):4263-4269.
PMID: 29660981
PMC: 5999404.
DOI: 10.1021/acs.jmedchem.8b00488.
Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.
Durek T, Cromm P, White A, Schroeder C, Kaas Q, Weidmann J
J Med Chem. 2018; 61(8):3674-3684.
PMID: 29605997
PMC: 5999400.
DOI: 10.1021/acs.jmedchem.8b00170.